Invention Grant
- Patent Title: Use of urea variants as affinity ligands
- Patent Title (中): 使用尿素变体作为亲和配体
-
Application No.: US10531783Application Date: 2003-09-12
-
Publication No.: US07645903B2Publication Date: 2010-01-12
- Inventor: Andreas Axén , Herbert Baumann , Enrique Carredano , Anna Grönberg , Elles Steensma
- Applicant: Andreas Axén , Herbert Baumann , Enrique Carredano , Anna Grönberg , Elles Steensma
- Applicant Address: SE Uppsala
- Assignee: GE Healthcare Bio-Sciences AB
- Current Assignee: GE Healthcare Bio-Sciences AB
- Current Assignee Address: SE Uppsala
- Agent Yonggang Ji
- Priority: SE0203226 20021031; SE0203878 20021220
- International Application: PCT/SE03/01434 WO 20030912
- International Announcement: WO2004/039765 WO 20040513
- Main IPC: C07C275/00
- IPC: C07C275/00 ; C07D213/81 ; A61P37/00 ; C07D233/34 ; A61K31/17

Abstract:
The present invention relates to an IgG-binding compound, which more specifically has affinity for human IgGs of κ-type and functional derivatives thereof. More specifically, the compound according to the invention comprises an N,N-alkylated urea moiety located between an aromatic part and another part, which is a linear or cyclic substituted or unsubstituted aliphatic group. The compound binds to a pocket-shaped binding site present on all human IgG κ-Fabs, which site is located between the two domains (CH1 and CL) of its constant part. Accordingly, the compound according to the invention is a ligand for human IgGs of κ-type, and consequently, the invention also relates to a separation matrix for affinity chromatography, which matrix comprises said compound, as well as to other uses of the compound.
Public/Granted literature
- US20060014735A1 Use of urea variants as affinity ligands Public/Granted day:2006-01-19
Information query